Scarica l'app Stockscreener
4.78
6.70%
0.30
Pre-mercato:
4.50
-0.28
-5.86%
Precedente Chiudi:
$4.48
Aprire:
$4.54
Volume 24 ore:
1.73M
Relative Volume:
15.03
Capitalizzazione di mercato:
$3.26M
Reddito:
-
Utile/perdita netta:
$-11.27M
Rapporto P/E:
-0.2232
EPS:
-21.4132
Flusso di cassa netto:
$-9.40M
1 W Prestazione:
-6.82%
1M Prestazione:
-9.13%
6M Prestazione:
-42.95%
1 anno Prestazione:
-65.11%
Intervallo 1D:
$4.54
$5.18
Intervallo di 1 settimana:
$4.22
$5.87
Portata 52W:
$4.22
$23.70
Dermata Therapeutics Inc Stock (DRMA) Company Profile
Nome
Dermata Therapeutics Inc
Settore
Industria
Telefono
(858)-223-0882
Indirizzo
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
Confronta DRMA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DRMA
Dermata Therapeutics Inc
|
4.78 | 3.05M | 0 | -11.27M | -9.40M | -21.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
Dermata Therapeutics Inc Borsa (DRMA) Ultime notizie
Short interest data insights for Dermata Therapeutics Inc. Equity WarrantForecast Cut & Stock Portfolio Risk Control - newser.com
What drives Dermata Therapeutics Inc stock priceMarket Correction Analysis & Low Risk Investment Tips - earlytimes.in
Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket - Benzinga
News impact scoring models applied to Dermata Therapeutics Inc. Equity Warrant2025 Price Momentum & Smart Money Movement Tracker - newser.com
What the charts say about Dermata Therapeutics Inc. Equity Warrant today2025 Fundamental Recap & Smart Allocation Stock Tips - newser.com
Is Dermata Therapeutics Inc. Equity Warrant stock a top pick in earnings seasonMarket Sentiment Report & Community Verified Trade Alerts - newser.com
Why Dermata Therapeutics Inc. Equity Warrant stock is a must watch in 2025Market Growth Summary & Real-Time Chart Breakout Alerts - newser.com
Why Dermata Therapeutics Inc. stock could outperform in 20252025 Market Trends & Risk Adjusted Swing Trade Ideas - newser.com
Measuring Dermata Therapeutics Inc. Equity Warrant’s beta against major indicesJuly 2025 Outlook & Weekly High Return Stock Opportunities - newser.com
What momentum shifts mean for Dermata Therapeutics Inc. Equity WarrantWeekly Trade Analysis & Consistent Profit Trade Alerts - newser.com
How buybacks impact Dermata Therapeutics Inc. Equity Warrant stock value2025 Investor Takeaways & Weekly Consistent Profit Watchlists - newser.com
Psyence Biomedical Stock Price, Quotes and Forecasts | NASDAQ:PBM - Benzinga
Advanced analytics toolkit walkthrough for Dermata Therapeutics Inc.Long Setup & Weekly Setup with ROI Potential - newser.com
Why Dermata Therapeutics Inc. stock remains a top recommendation2025 Geopolitical Influence & Accurate Buy Signal Alerts - newser.com
Australian patent office accepts Dermata’s acne treatment patent By Investing.com - Investing.com Canada
Australian patent office accepts Dermata’s acne treatment patent - Investing.com Australia
Once-Weekly Acne Treatment Breakthrough: Dermata's Novel Technology Gets Australian Patent Green Light - Stock Titan
Primary Axillary Hyperhidrosis Pipeline 2025: Key Clinical - openPR.com
Primary Axillary Hyperhidrosis Pipeline 2025: Key Clinical Developments By 5+ Global Leaders Delveinsight Featuring Brickell Biotech Inc., Dermata Therapeutics LLC, Dr. August Wolff Gmbh & Co. KG - Menafn.com
Can swing trading help recover from Dermata Therapeutics Inc. losses2025 Market Overview & Long-Term Growth Stock Strategies - newser.com
Real time breakdown of Dermata Therapeutics Inc. stock performance2025 Major Catalysts & Smart Money Movement Alerts - newser.com
ProShares Trust ProShares Ultra Consumer Staples Stock Analysis and ForecastVolatility Adjusted Trading & Minimal Investment Capital Gains - earlytimes.in
Dermata Therapeutics Inc Azioni (DRMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.05%
4.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):